No Data
No Data
Novo Nordisk Is Maintained at Outperform by BMO Capital
Novo Nordisk Drops on Q2 Earnings and Sales Miss Despite Raised Outlook
Novo Nordisk Analyst Ratings
Eli Lilly Shows We Haven't Hit Peak Obesity Yet -- WSJ
European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading
Express News | Novo Nordisk Shares Are Trading Higher. The Stock May Be up After Eli Lily Raised Its Guidance, Primarily Driven by the Performance of Mounjaro and Zepbound
Silverbat : Interest stays?